Literature DB >> 30526358

Radiomics of Brain MRI: Utility in Prediction of Metastatic Tumor Type.

Helge C Kniep1, Frederic Madesta1, Tanja Schneider1, Uta Hanning1, Michael H Schönfeld1, Gerhard Schön1, Jens Fiehler1, Tobias Gauer1, René Werner1, Susanne Gellissen1.   

Abstract

Purpose To investigate the feasibility of tumor type prediction with MRI radiomic image features of different brain metastases in a multiclass machine learning approach for patients with unknown primary lesion at the time of diagnosis. Materials and methods This single-center retrospective analysis included radiomic features of 658 brain metastases from T1-weighted contrast material-enhanced, T1-weighted nonenhanced, and fluid-attenuated inversion recovery (FLAIR) images in 189 patients (101 women, 88 men; mean age, 61 years; age range, 32-85 years). Images were acquired over a 9-year period (from September 2007 through December 2016) with different MRI units, reflecting heterogeneous image data. Included metastases originated from breast cancer (n = 143), small cell lung cancer (n = 151), non-small cell lung cancer (n = 225), gastrointestinal cancer (n = 50), and melanoma (n = 89). A total of 1423 quantitative image features and basic clinical data were evaluated by using random forest machine learning algorithms. Validation was performed with model-external fivefold cross validation. Comparative analysis of 10 randomly drawn cross-validation sets verified the stability of the results. The classifier performance was compared with predictions from a respective conventional reading by two radiologists. Results Areas under the receiver operating characteristic curve of the five-class problem ranged between 0.64 (for non-small cell lung cancer) and 0.82 (for melanoma); all P values were less than .01. Prediction performance of the classifier was superior to the radiologists' readings. Highest differences were observed for melanoma, with a 17-percentage-point gain in sensitivity compared with the sensitivity of both readers; P values were less than .02. Conclusion Quantitative features of routine brain MR images used in a machine learning classifier provided high discriminatory accuracy in predicting the tumor type of brain metastases. © RSNA, 2018 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2018        PMID: 30526358     DOI: 10.1148/radiol.2018180946

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  56 in total

1.  Radiomics approach in the neurodegenerative brain.

Authors:  Christian Salvatore; Isabella Castiglioni; Antonio Cerasa
Journal:  Aging Clin Exp Res       Date:  2019-08-19       Impact factor: 3.636

2.  Quality of science and reporting of radiomics in oncologic studies: room for improvement according to radiomics quality score and TRIPOD statement.

Authors:  Ji Eun Park; Donghyun Kim; Ho Sung Kim; Seo Young Park; Jung Youn Kim; Se Jin Cho; Jae Ho Shin; Jeong Hoon Kim
Journal:  Eur Radiol       Date:  2019-07-26       Impact factor: 5.315

3.  Automated machine learning based on radiomics features predicts H3 K27M mutation in midline gliomas of the brain.

Authors:  Xiaorui Su; Ni Chen; Huaiqiang Sun; Yanhui Liu; Xibiao Yang; Weina Wang; Simin Zhang; Qiaoyue Tan; Jingkai Su; Qiyong Gong; Qiang Yue
Journal:  Neuro Oncol       Date:  2020-03-05       Impact factor: 12.300

4.  Radiomics as prognostic factor in brain metastases treated with Gamma Knife radiosurgery.

Authors:  Chih-Ying Huang; Cheng-Chia Lee; Huai-Che Yang; Chung-Jung Lin; Hsiu-Mei Wu; Wen-Yuh Chung; Cheng-Ying Shiau; Wan-Yuo Guo; David Hung-Chi Pan; Syu-Jyun Peng
Journal:  J Neurooncol       Date:  2020-02-04       Impact factor: 4.130

5.  A preliminary study using spinal MRI-based radiomics to predict high-risk cytogenetic abnormalities in multiple myeloma.

Authors:  Jianfang Liu; Chunjie Wang; Wei Guo; Piaoe Zeng; Yan Liu; Ning Lang; Huishu Yuan
Journal:  Radiol Med       Date:  2021-06-22       Impact factor: 3.469

Review 6.  Precision Digital Oncology: Emerging Role of Radiomics-based Biomarkers and Artificial Intelligence for Advanced Imaging and Characterization of Brain Tumors.

Authors:  Reza Forghani
Journal:  Radiol Imaging Cancer       Date:  2020-07-31

7.  The radiomic-clinical model using the SHAP method for assessing the treatment response of whole-brain radiotherapy: a multicentric study.

Authors:  Yixin Wang; Jinwei Lang; Joey Zhaoyu Zuo; Yaqin Dong; Zongtao Hu; Xiuli Xu; Yongkang Zhang; Qinjie Wang; Lizhuang Yang; Stephen T C Wong; Hongzhi Wang; Hai Li
Journal:  Eur Radiol       Date:  2022-06-09       Impact factor: 5.315

8.  Magnetic resonance imaging (MRI) radiomics of papillary thyroid cancer (PTC): a comparison of predictive performance of multiple classifiers modeling to identify cervical lymph node metastases before surgery.

Authors:  Hui Qin; Qiao Que; Peng Lin; Xin Li; Xin-Rong Wang; Yun He; Jun-Qiang Chen; Hong Yang
Journal:  Radiol Med       Date:  2021-07-08       Impact factor: 3.469

9.  Diffusion tensor and postcontrast T1-weighted imaging radiomics to differentiate the epidermal growth factor receptor mutation status of brain metastases from non-small cell lung cancer.

Authors:  Yae Won Park; Chansik An; JaeSeong Lee; Kyunghwa Han; Dongmin Choi; Sung Soo Ahn; Hwiyoung Kim; Sung Jun Ahn; Jong Hee Chang; Se Hoon Kim; Seung-Koo Lee
Journal:  Neuroradiology       Date:  2020-08-21       Impact factor: 2.804

10.  Comparison of radiomic feature aggregation methods for patients with multiple tumors.

Authors:  Enoch Chang; Marina Z Joel; Hannah Y Chang; Justin Du; Omaditya Khanna; Antonio Omuro; Veronica Chiang; Sanjay Aneja
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.